全文获取类型
收费全文 | 12279篇 |
免费 | 1386篇 |
国内免费 | 531篇 |
专业分类
耳鼻咽喉 | 194篇 |
儿科学 | 288篇 |
妇产科学 | 342篇 |
基础医学 | 1531篇 |
口腔科学 | 592篇 |
临床医学 | 1332篇 |
内科学 | 2040篇 |
皮肤病学 | 158篇 |
神经病学 | 814篇 |
特种医学 | 318篇 |
外国民族医学 | 3篇 |
外科学 | 1660篇 |
综合类 | 1078篇 |
一般理论 | 1篇 |
预防医学 | 758篇 |
眼科学 | 331篇 |
药学 | 1329篇 |
4篇 | |
中国医学 | 351篇 |
肿瘤学 | 1072篇 |
出版年
2023年 | 142篇 |
2022年 | 180篇 |
2021年 | 407篇 |
2020年 | 361篇 |
2019年 | 466篇 |
2018年 | 474篇 |
2017年 | 406篇 |
2016年 | 378篇 |
2015年 | 587篇 |
2014年 | 732篇 |
2013年 | 747篇 |
2012年 | 919篇 |
2011年 | 959篇 |
2010年 | 727篇 |
2009年 | 556篇 |
2008年 | 730篇 |
2007年 | 801篇 |
2006年 | 671篇 |
2005年 | 606篇 |
2004年 | 516篇 |
2003年 | 422篇 |
2002年 | 369篇 |
2001年 | 243篇 |
2000年 | 230篇 |
1999年 | 197篇 |
1998年 | 127篇 |
1997年 | 138篇 |
1996年 | 108篇 |
1995年 | 79篇 |
1994年 | 87篇 |
1993年 | 86篇 |
1992年 | 90篇 |
1991年 | 107篇 |
1990年 | 109篇 |
1989年 | 93篇 |
1988年 | 76篇 |
1987年 | 50篇 |
1986年 | 39篇 |
1985年 | 26篇 |
1984年 | 24篇 |
1983年 | 17篇 |
1982年 | 10篇 |
1981年 | 13篇 |
1980年 | 14篇 |
1979年 | 12篇 |
1978年 | 8篇 |
1977年 | 13篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1974年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
ChiaChi Lin TsaiSheng Yang ChiaJui Yen Rebecca Cheng Junjun Liu Chiun Hsu 《The oncologist》2020,25(12)
Lessons Learned
- The combination of ramucirumab (8 mg/kg intravenous, day 1 every 2 weeks) and FOLFOX4 as first‐line treatment in patients with advanced hepatocellular carcinoma (HCC) was not sufficiently tolerated.
- Preliminary efficacy data suggest that the combination may provide clinical benefit to patients with HCC.
- Dose modification and patient selection should be considered for the future development of ramucirumab plus FOLFOX chemotherapy for advanced HCC.
5.
6.
Pedro Fong Cheng N. Ao Kai I. Tou Ka M. Huang Chi C. Cheong Li R. Meng 《Oncology research》2019,27(2):237-251
The aim of this study was to investigate the inhibition effects of cordycepin and its derivatives on endometrial
cancer cell growth. Cytotoxicity MTT assays, clonogenic assays, and flow cytometry were used to observe
the effects on apoptosis and regulation of the cell cycle of Ishikawa cells under various concentrations of
cordycepin, cisplatin, and combinations of the two. Validated in silico docking simulations were performed
on 31 cordycepin derivatives against adenosine deaminase (ADA) to predict their binding affinities and hence
their potential tendency to be metabolized by ADA. Cordycepin has a significant dose-dependent inhibitory
effect on cell proliferation. The combination of cordycepin and cisplatin produced greater inhibition effects
than did cordycepin alone. Apoptosis investigations confirmed the ability of cordycepin to induce the apoptosis of Ishikawa cells. The in silico results indicate that compound MRS5698 is least metabolized by ADA
and has acceptable drug likeness and safety profiles. This is the first study to confirm the cytotoxic effects of
cordycepin on endometrial cancer cells. This study also identified cordycepin derivatives with promising pharmacological and pharmacokinetic properties for further investigation in the development of new treatments for
endometrial cancer 相似文献
7.
Chi Andrew S. Tarapore Rohinton S. Hall Matthew D. Shonka Nicole Gardner Sharon Umemura Yoshie Sumrall Ashley Khatib Ziad Mueller Sabine Kline Cassie Zaky Wafik Khatua Soumen Weathers Shiao-Pei Odia Yazmin Niazi Toba N. Daghistani Doured Cherrick Irene Korones David Karajannis Matthias A. Kong Xiao-Tang Minturn Jane Waanders Angela Arillaga-Romany Isabel Batchelor Tracy Wen Patrick Y. Merdinger Krystal Schalop Lee Stogniew Martin Allen Joshua E. Oster Wolfgang Mehta Minesh P. 《Journal of neuro-oncology》2019,144(1):97-105
Journal of Neuro-Oncology - Smoking is agreed to be a major health risk factor, but it is debated whether it has an influence on perioperative adverse events (AEs) in elective cranial tumor... 相似文献
8.
9.
目的:通过对颈椎病患者上下终板弧形高度、椎间隙高度与椎间隙后骨赘的影像学测量,研究其相关性及其临床应用价值。方法:收集2017年9月至2018年9月颈椎病手术108例患者的临床资料,男48例,年龄30~72岁,平均52岁,女60例,年龄37~79岁,平均54岁。其中C2,3 6例,C3,4 15例,C4,5 32例,C5,6 42例,C6,7 13例。术前及术后摄颈椎X线片,利用PACS(Picture Archiving and Communication Systems)调阅影像,测量椎间隙的下上终板弧形高度(L1,L2),椎间隙高度(L3)及后方骨赘的宽度(L4)。利用Spearman分析它们之间的相关性。结果:L1与L4对比(r=-0.34,P<0.05),L3与L4对比(r=-0.36,P<0.05),存在负相关。L1与L3对比(r=0.38,P<0.05),L2与L3对比(r=0.48,P<0.05),存在正相关。L1与L2对比(P>0.05),L2与L4对比(P>0.05),差异无统计学意义。结论:下终板弧形高度与椎间隙后缘骨赘宽度呈负相关,通过其测量可明确颈椎退变程度,对颈椎病的早期防治有指导意义。 相似文献
10.
This systematic review employed a meta-analysis to examine the effectiveness of art therapy for treating anxiety, depression, and fatigue in female patients with breast cancer, the most prevalent cancer and the most common cause of cancer-related mortality among women worldwide. The review included nine original studies and analyzed data from a total of 754 patients. Data extraction and quality assessment were conducted by two independent reviewers. In total, 1,466 articles were retrieved. We excluded studies in which the participant, interventions, and study design did not satisfy the inclusion criteria, leaving nine articles for analysis, The Cochrane risk of bias assessment tools were used for quality evaluation. The analysis revealed a significant difference in treatment outcomes between patients who received art therapy and those who did not (SMD?=?–0.48, 95%CI [–0.75, –0.21, p?=?0.0005]). The review provides initial evidence to suggest that art therapy benefits female breast cancer patients with respect to the treatment of anxiety, depression, and fatigue. However, additional and better-quality studies must be conducted, particularly with larger sample sizes, greater specificity of the design of trials and interventions, and a longer follow-up duration. 相似文献